Sedation with remimazolam for heart ultrasound
Treatments studied
Part of Heart & circulation clinical trials.
This study tests a medicine called remimazolam to see how well it works for sedation (helping you relax and stay comfortable) during a TEE procedure, which is an ultrasound of the heart from the inside. If you are a heart patient having a planned TEE, this trial might help improve your experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be a heart patient having a scheduled (not emergency) TEE – a test that uses sound waves to look at your heart from the inside.
- You must not be allergic to dextrans (a type of sugar solution used in some medical products).
- You must not be allergic to any anesthesia medicines (drugs that put you to sleep or calm you during procedures).
- You must agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer anesthetic drug, remimazolam, during heart surgery that uses a heart-lung machine. It aims to see if it is safe and works well for patients having this type of surgery.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This trial compares two sedative medicines (remimazolam and propofol) given during heart ablation procedures. The study uses brain-wave monitoring to see which medicine provides better sedation and recovery. It's for people who are already scheduled for this procedure with a specific doctor.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial tests a sedative called remimazolam for people with serious health conditions who need an ERCP, a procedure to examine the bile ducts. It aims to find a safer sedation option for those at higher risk.
Hear when a new Cardiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.